What Escalon Medical Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| DePiano Richard J Jr | President | Dec 17 | Disposition to Issuer · D | +500 | $1.08 | +$538 | 127,706 |
| Depiano Richard J | Chairman & CEO | Oct 11 | Exercise / conversion · M | +112,500 | $2.25 | +$253K | 144,278 |
| Odonnell Jeffrey F | Director | Dec 06 | Open-market sale · S | −10,000 | $9.42 | −$94.2K | 0 |
| Odonnell Jeffrey F | Director | Dec 06 | Exercise / conversion · M | +10,000 | $2.38 | +$23.8K | 0 |
| Odonnell Jeffrey F | Director | Mar 04 | Open-market sale · S | −5,000 | $16.40 | −$82K | 0 |
| Odonnell Jeffrey F | Director | Mar 04 | Exercise / conversion · M | +5,000 | $2.13 | +$10.6K | 0 |
| Depiano Richard J | Chairman & CEO | Mar 04 | Open-market sale · S | −16,000 | $17.46 | −$279K | 31,778 |
| Depiano Richard J | Chairman & CEO | Mar 04 | Exercise / conversion · M | +16,000 | $2.13 | +$34K | 31,778 |
| Coppola Anthony J | Director | Mar 04 | Open-market sale · S | −10,000 | $16.54 | −$165K | 0 |
| Coppola Anthony J | Director | Mar 04 | Exercise / conversion · M | +10,000 | $2.77 | +$27.7K | 0 |
| Coppola Anthony J | Director | Mar 04 | Open-market sale · S | −10,000 | $16.54 | −$165K | 0 |
| Coppola Anthony J | Director | Mar 04 | Exercise / conversion · M | +10,000 | $2.38 | +$23.8K | 0 |
| Napolitano Lisa A | Director | Mar 04 | Open-market sale · S | +8,000 | $16.14 | +$129K | 0 |
| Napolitano Lisa A | Director | Mar 04 | Exercise / conversion · M | +8,000 | $6.94 | +$55.5K | 0 |
| Federman Jay L Md | Director | Mar 03 | Open-market sale · S | −10,000 | $16.63 | −$166K | 12,072 |
| Federman Jay L Md | Director | Mar 03 | Open-market sale · S | −5,000 | $16.63 | −$83.2K | 22,072 |
| Federman Jay L Md | Director | Mar 03 | Exercise / conversion · M | +5,000 | $2.77 | +$13.9K | 22,072 |
| Federman Jay L Md | Director | Mar 03 | Open-market sale · S | −10,000 | $16.63 | −$166K | 22,072 |
| Federman Jay L Md | Director | Mar 03 | Exercise / conversion · M | +10,000 | $2.38 | +$23.8K | 22,072 |
| Federman Jay L Md | Director | Mar 03 | Open-market sale · S | −5,000 | $16.63 | −$83.2K | 22,072 |
Loading...
